ATAI Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ATAI shares is 105, representing 26.67% of the company's common stock.

HIGHTOWER ADVISORS, LLC, in the last quarter, reduced its stake in ATAI by -1.67% restricting it's holding to 44.19 thousand shares of worth nearly $87.00K. QUBE RESEARCH & TECHNOLOGIES LTD also lessened -60.66% of the ATAI shares from its portfolio, reducing its holding to 50.56 thousand shares of worth $99.60K. CERITY PARTNERS LLC also shunned ATAI shares holding by -47.41% last quarter which brought its holding to 51.52 thousand shares worth $101.50K.

As per its latest 13F filing, OBJECTIVITY SQUARED, LLC increased its stake in ATAI by 4.73% in the last quarter. The institutional holder raised its holding to 44.26 thousand shares having worth more than $107.55K. AMERICAN CENTURY COMPANIES INC also added 100% more shares of ATAI to its portfolio, raising its holding to 46.63 thousand shares of worth $91.86K. ROYAL BANK OF CANADA also increased its ATAI shares holding by 3.13% which brought its holding to 51.72 thousand shares worth $102.00K.

The insider with the most stakes in ATAI is Apeiron Investment Group Ltd. , 10 percent owner at the company. Additionally, ATAI stock is highly held by 10 percent owner ATAI Life Sciences N.V. and director Auerbach Michael among others.

Company executives, directors, and other insiders own 10% percent of Atai Life Sciences N.V.'s stock. Within the last six months, there have been 0 transaction(s) in which ATAI insiders have sold stock, totaling 0 shares. Insiders that have sold shares include BRAND FLORIAN, JOHNSON ANNE NAGENGAST, and RAO SRINIVAS.

There have been 1 transaction(s) during the past 6-months in which Atai Life Sciences N.V. insiders have bought stock, totalling 10835718 shares

Around 40.56M Atai Life Sciences N.V. shares are held by insiders, which represents about 10% of ATAI stock.

ATAI 10 percent owner, Apeiron Investment Group Ltd. holds the largest portfolio of the company's shares. ATAI shares owned by Apeiron total nearly 40.56 million.

HIGHTOWER ADVISORS, LLC is the largest institutional owner in ATAI which holds 44.19 thousand shares worth $87.00K or 0.03% of the total ATAI shares outstanding followed by OBJECTIVITY SQUARED, LLC with ownership of 44.26 thousand shares representing 0.03% of the ATAI ownership. AMERICAN CENTURY COMPANIES INC is the third largest stakeholder with 46.63 thousand shares or 0.03% of the ownership worth more than $91.86K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ATAI is concerned, it is a stock which is optionable.

Number of ATAI shares short is 11.31M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 167.80M shares of ATAI are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ATAI has 123.13M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ATAI is 6.49.